Company seeks approval for first drug that could slow Alzheimer’s disease
Campaigners have welcomed steps towards approving a potentially “groundbreaking” drug treatment for people with Alzheimer’s. Drug maker Biogen said it was seeking regulatory approval for aducanumab in the US on
Read More